mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
1e-17 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-10 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-08 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-08 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |